Cinchocaine: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Protected "Cinchocaine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
m (Protected "Cinchocaine": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(8 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{drugbox
{{Drugbox
| IUPAC_name = 2-butoxy-''N''-(2-diethylaminoethyl) quinoline-4-carboxamide
| Watchedfields = changed
| image =
| verifiedrevid = 460037677
| IUPAC_name = 2-butoxy-''N''-[2-(diethylamino)ethyl]quinoline-4-carboxamide
| image = Cinchocaine Wiki Str.png
| image2 = Cinchocaine BnS.png
 
<!--Clinical data-->
| tradename = 
| Drugs.com = {{drugs.com|international|cinchocaine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = OTC
| legal_status = 
| routes_of_administration = topical, intravenous (equine euthanasia)
 
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
 
<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 85-79-0
| CAS_number = 85-79-0
| ATC_prefix = C05
| ATC_prefix = C05
| ATC_suffix = AD04  
| ATC_suffix = AD04
| ATC_supplemental = {{ATC|D04|AB02}} {{ATC|N01|BB06}} {{ATC|S01|HA06}}
| ATC_supplemental = {{ATC|D04|AB02}} {{ATC|N01|BB06}} {{ATC|S01|HA06}} {{ATC|S02|DA04}}
| PubChem = 3025
| PubChem = 3025
| DrugBank = APRD00915
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| C = 20 | H = 29 | N = 3 | O = 2
| DrugBank = DB00527
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2917
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = L6JW2TJG99
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00733
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 247956
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1086
 
<!--Chemical data-->
| C=20 | H=29 | N=3 | O=2
| molecular_weight = 343.463 g/mol
| molecular_weight = 343.463 g/mol
| bioavailability =  
| smiles = O=C(c1c2ccccc2nc(OCCCC)c1)NCCN(CC)CC
| protein_bound =  
| InChI = 1/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)
| metabolism =  
| InChIKey = PUFQVTATUTYEAL-UHFFFAOYAU
| elimination_half-life =  
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| excretion =
| StdInChI = 1S/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| pregnancy_US = <!-- A / B / C / D / X -->
| StdInChIKey = PUFQVTATUTYEAL-UHFFFAOYSA-N
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =  
| routes_of_administration =  
}}
}}
__NOTOC__
{{SI}}
{{CMG}}
== Overview ==
'''Cinchocaine''' ([[International Nonproprietary Name|INN]]/[[British Approved Name|BAN]]) or '''dibucaine''' ([[United States Adopted Name|USAN]]) is an [[amide]] [[local anesthetic]]. Among the most potent and toxic of the long-acting local anesthetics, current use of cinchocaine is generally restricted to spinal and topical anesthesia.<ref>Martindale, The Extra Pharmacopoeia, 30th ed, p1006</ref><ref>[http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?mode=&term=Dibucaine Dibucaine]</ref> It is sold under the brand names '''Cincain''', '''Nupercainal''', '''Nupercaine''' and '''Sovcaine'''.


==Overview==
==Medical use==
'''Cinchocaine''' (or '''Dibucaine''') is an [[amide]] [[local anesthetic]].  It is the active ingredient in some topical hemorrhoid creams.
Cinchocaine is the active ingredient in some topical hemorrhoid creams such as [[Proctosedyl]]. It is also a component of the [[veterinary]] drug '''Somulose''', used for [[animal euthanasia|euthanasia]] of [[horse]]s and [[cattle]].


It is also a component of the [[veterinary]] drug '''Somulose''', used for [[animal euthanasia|euthanasia]] of horses and cattle.
==Physical properties==
Cinchocaine is relatively [[insoluble]] in [[alkaline]] aquatic solutions.


==External links==
==See also==
* {{cite journal | author = Abdel-Ghani N, Youssef A, Awady M | title = Cinchocaine hydrochloride determination by atomic absorption spectrometry and spectrophotometry. | journal = Farmaco | volume = 60 | issue = 5 | pages = 419-24 | year = 2005 | id = PMID 15910814}}
* [[Dibucaine number]]
* {{cite journal | author = Souto-Padron T, Lima AP, de Oliveira Ribeiro R. | title = Effects of dibucaine on the endocytic/exocytic pathways in Trypanosoma cruzi. | journal = Parasitol Res | volume = | issue = | pages = | year = 2006 | id = PMID 16612626}}
 
* {{cite journal | author = Nounou M, El-Khordagui L, Khalafallah N | title = Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles. | journal = Acta Pol Pharm | volume = 62 | issue = 5 | pages = 369-79 | year = | id = PMID 16459486}}
==References==
{{reflist|2}}
 
==Further reading==
* {{cite journal | author = Abdel-Ghani N, Youssef A, Awady M | title = Cinchocaine hydrochloride determination by atomic absorption spectrometry and spectrophotometry. | journal = Farmaco | volume = 60 | issue = 5 | pages = 419–24 | year = 2005 | pmid = 15910814 | doi = 10.1016/j.farmac.2005.03.001}}
* {{cite journal | author = Souto-Padron T, Lima AP, de Oliveira Ribeiro R. | title = Effects of dibucaine on the endocytic/exocytic pathways in Trypanosoma cruzi. | journal = Parasitol Res | volume = 99| issue = 4| pages = 317–20| year = 2006 | pmid = 16612626 | doi = 10.1007/s00436-006-0192-1}}
* {{cite journal | author = Nounou M, El-Khordagui L, Khalafallah N | title = Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles. | journal = Acta Pol Pharm | volume = 62 | issue = 5 | pages = 369–79 | year = 2005| pmid = 16459486}}
* {{cite journal | author = Aroti,A.;Leontidis, E. | title =  Simultaneous Determination of the Ionization Constant and the Solubility of Sparingly Soluble Drug Substances. A Physical Chemistry Experiment . | journal = Journal of Chemical Education| volume = 78 | issue =  6 | pages = 786–788 | year = 2001 | doi = 10.1021/ed078p786}}


{{Vasoprotectives}}
{{Vasoprotectives}}
{{Antipruritics}}
{{Antipruritics}}
{{local anesthetics}}
{{local anesthetics}}
{{dermatologic-drug-stub}}
{{nervous-system-drug-stub}}


[[Category:Drug]]
[[Category:Local anesthetics]]
[[Category:Local anesthetics]]
{{SIB}}
[[Category:Quinolines]]
{{WikiDoc Help Menu}}
[[Category:Phenol ethers]]
 
[[Category:Amides]]
{{WS}}

Latest revision as of 19:08, 18 August 2015

Cinchocaine
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration		topical, intravenous (equine euthanasia)
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC20H29N3O2
Molar mass343.463 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Cinchocaine

Articles

Most recent articles on Cinchocaine

Most cited articles on Cinchocaine

Review articles on Cinchocaine

Articles on Cinchocaine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cinchocaine

Images of Cinchocaine

Photos of Cinchocaine

Podcasts & MP3s on Cinchocaine

Videos on Cinchocaine

Evidence Based Medicine

Cochrane Collaboration on Cinchocaine

Bandolier on Cinchocaine

TRIP on Cinchocaine

Clinical Trials

Ongoing Trials on Cinchocaine at Clinical Trials.gov

Trial results on Cinchocaine

Clinical Trials on Cinchocaine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cinchocaine

NICE Guidance on Cinchocaine

NHS PRODIGY Guidance

FDA on Cinchocaine

CDC on Cinchocaine

Books

Books on Cinchocaine

News

Cinchocaine in the news

Be alerted to news on Cinchocaine

News trends on Cinchocaine

Commentary

Blogs on Cinchocaine

Definitions

Definitions of Cinchocaine

Patient Resources / Community

Patient resources on Cinchocaine

Discussion groups on Cinchocaine

Patient Handouts on Cinchocaine

Directions to Hospitals Treating Cinchocaine

Risk calculators and risk factors for Cinchocaine

Healthcare Provider Resources

Symptoms of Cinchocaine

Causes & Risk Factors for Cinchocaine

Diagnostic studies for Cinchocaine

Treatment of Cinchocaine

Continuing Medical Education (CME)

CME Programs on Cinchocaine

International

Cinchocaine en Espanol

Cinchocaine en Francais

Business

Cinchocaine in the Marketplace

Patents on Cinchocaine

Experimental / Informatics

List of terms related to Cinchocaine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cinchocaine (INN/BAN) or dibucaine (USAN) is an amide local anesthetic. Among the most potent and toxic of the long-acting local anesthetics, current use of cinchocaine is generally restricted to spinal and topical anesthesia.[1][2] It is sold under the brand names Cincain, Nupercainal, Nupercaine and Sovcaine.

Medical use

Cinchocaine is the active ingredient in some topical hemorrhoid creams such as Proctosedyl. It is also a component of the veterinary drug Somulose, used for euthanasia of horses and cattle.

Physical properties

Cinchocaine is relatively insoluble in alkaline aquatic solutions.

See also

References

  1. ↑ Martindale, The Extra Pharmacopoeia, 30th ed, p1006
  2. ↑ Dibucaine

Further reading

  • Abdel-Ghani N, Youssef A, Awady M (2005). "Cinchocaine hydrochloride determination by atomic absorption spectrometry and spectrophotometry". Farmaco. 60 (5): 419–24. doi:10.1016/j.farmac.2005.03.001. PMID 15910814.
  • Souto-Padron T, Lima AP, de Oliveira Ribeiro R. (2006). "Effects of dibucaine on the endocytic/exocytic pathways in Trypanosoma cruzi". Parasitol Res. 99 (4): 317–20. doi:10.1007/s00436-006-0192-1. PMID 16612626.
  • Nounou M, El-Khordagui L, Khalafallah N (2005). "Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles". Acta Pol Pharm. 62 (5): 369–79. PMID 16459486.
  • Aroti,A.;Leontidis, E. (2001). "Simultaneous Determination of the Ionization Constant and the Solubility of Sparingly Soluble Drug Substances. A Physical Chemistry Experiment". Journal of Chemical Education. 78 (6): 786–788. doi:10.1021/ed078p786.

Template:Vasoprotectives Template:Antipruritics

Template:Dermatologic-drug-stub Template:Nervous-system-drug-stub

Retrieved from "https://www.wikidoc.org/index.php?title=Cinchocaine&oldid=1135017"